by Peter | Mar 17, 2022 | MS Medications, Research
Posted on December 30, 2021 (20) (81) (15) Medically reviewed byAmit M. Shelat, D.O. Article written byBrooke Dulka, Ph.D. Highly effective (HE) disease-modifying treatments (DMTs) can help slow progression of multiple sclerosis (MS) and reduce...
by Peter | Dec 14, 2021 | Research, VISION
By Benjamin Segal, MD, as told to Kara Mayer Robinson We’ve come a long way in treating MS — it’s been one of the biggest success stories in medicine. Over the last 20 years, there has been a revolution in drugs that change the course of the disease,...
by Peter | Nov 14, 2021 | Research, VISION
Solutions for People with MS November 9, 2021MS healthcare providers and researchers participated in the 35th Annual Meeting of the Consortium of MS Centers (CMSC) in Orlando, Florida, to share findings and learn the latest about diagnosing and treating MS, and to...
by Peter | Nov 10, 2021 | Research, VIABILITY, VISION
MNT’s Sunday Supplement: Genetic evidence links vitamin D deficiency to mortality risk in someVitamin D is a topic Medical News Today keeps coming back to. We have covered research into the link between vitamin D and the microbiome, the mixed evidence for the health...
by Peter | Nov 2, 2021 | Research, VISION
Spinal cord lesions are more commonly seen in progressive forms of multiple sclerosis, and they can result in an increased risk of disability. Nearly everyone with multiple sclerosis (MS) has signs of lesions in the brain, as shown by magnetic resonance imaging...